To model the suprabasal expression of PPARβ/δ observed in psoriasis in humans, we initially intended to target transgenic PPARβ/δ expression using a “conventional” promoter active in suprabasal epidermis, e.g. the involucrin promoter. Here, PPARD is linked to psoriasis.